The best Bull and Bear pitches based on recency and number of recommendations.
Cynapsus is starting phase 3 trial for it's candidate drug for OFF episodes associated with Parkinson's disease. The NDA should get filed in 2016. If succesful, there's huge upside and a great chance that the company gets acquired.
In the land of the skunks he who has half a nose is king.Farley
Read the most recent pitches from players about CYNA.
Recs
TMusta
(29.29)
Submitted: 3/20/2015 6:59:33 AM :
Start Price:
$16.32
NASDAQ OTC:CYNA Score:
-97.83
Cynapsus is starting phase 3 trial for it's candidate drug for OFF episodes associated with Parkinson's disease. The NDA should get filed in 2016. If succesful, there's huge upside and a great chance that the company gets acquired.
Find the members with the highest scoring picks in CYNA.
redfox18 (99.85) Score: +65.90
The Score Leader is the player with the highest score across all their picks in CYNA.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| JoeySolitro1 | 99.99 | 8/22/2014 |
|
5Y | $8.87 | +66.88% | +98.04% | +31.16 | 0 Comment | |
| TMusta | 29.29 | 3/20/2015 |
|
3Y | $16.32 | -9.31% | +88.52% | -97.83 | 1 Comment | |
| 33fool | < 20 | 2/18/2015 |
|
5Y | $18.56 | -20.26% | +88.56% | -108.82 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
